Cyteir Therapeutics is a biotechnology business based in the US. Cyteir Therapeutics stocks (CYT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $18.23 – a decrease of 19.42% over the previous week. Cyteir Therapeutics employs 22 staff and has a market cap (total outstanding stock value) of $216.5 million.
How to buy shares in Cyteir Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CYT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Cyteir Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Cyteir Therapeutics?
- Cyteir Therapeutics shares summary
- Compare share dealing platforms
- Is Cyteir Therapeutics stock a buy or sell?
- Cyteir Therapeutics performance over time
- Cyteir Therapeutics's financials
- Does Cyteir Therapeutics pay a dividend?
- Have Cyteir Therapeutics shares ever split?
- Other common questions
Cyteir Therapeutics stock price (NASDAQ:CYT)Use our graph to track the performance of CYT stocks over time.
Cyteir Therapeutics shares at a glance
|Latest market close||$5.81|
|52-week range||$5.76 - $23.10|
|50-day moving average||$12.66|
|200-day moving average||$16.48|
|Wall St. target price||$31.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.20|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Cyteir Therapeutics price performance over time
|1 week (2022-01-12)||-19.42%|
|1 month (2021-12-17)||-41.31%|
|3 months (2021-10-19)||-67.47%|
|6 months (2021-07-19)||-66.16%|
|1 year (2021-01-15)||N/A|
|2 years (2020-01-15)||N/A|
|3 years (2019-01-15)||N/A|
|5 years (2017-01-15)||N/A|
Cyteir Therapeutics financials
|Gross profit TTM||$-16,591,000|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$216.5 million|
TTM: trailing 12 months
Cyteir Therapeutics share dividends
We're not expecting Cyteir Therapeutics to pay a dividend over the next 12 months.
Have Cyteir Therapeutics's shares ever split?
Cyteir Therapeutics's shares were split on a 2:1 basis on 18 September 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cyteir Therapeutics shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cyteir Therapeutics shares which in turn could have impacted Cyteir Therapeutics's share price.
Cyteir Therapeutics overview
Cyteir Therapeutics, Inc. operates as a clinical-stage oncology company that develops novel therapeutics based on the biology of DNA repair for the treatment of cancer and synthetic lethality therapeutics for autoimmune diseases. The company engages in manufacturing therapeutics that provide precision targeting of key DNA repair factors to induce diseased cells to self-destruct by DNA damage overload and uses an integrated drug development platform that modulates the imbalance between DNA damage and repair for the therapeutic effect to deliver a pipeline of small molecule therapeutics with a range of potential disease state applications. It provides CYT-0851, an oral small-molecule inhibitor of RAD51-mediated DNA repair. It focuses on providing treatments for a range of hematological malignancies, solid tumors, and chronic autoimmune disorders. The company was incorporated in 2012 and is based in Lexington, Massachusetts. .
Stocks similar to Cyteir Therapeutics
Frequently asked questions
Cyteir Therapeutics in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Cyteir Therapeutics Inc Shares Close the Week 25.8% Lower - Weekly Wrap
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.
FUNToken (FUN) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy FUNToken, lists some exchanges where you can get it and provides daily price data on FUN.
Ask an Expert
You must be logged in to post a comment.